University of Wisconsin, Madison: Lung Neoplasms trials
The registry lists 17 Lung Neoplasms studies with University of Wisconsin, Madison as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 1 8Phase 2 5Phase 3 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung CancerCompletedNCT00798720Phase 2Results posted
- Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint InhibitionTerminatedNCT03275597Phase 1
- Impacts of Exercise on Prognostic Biomarkers in Lung Cancer PatientsCompletedNCT01999881Not applicable
- Evaluating an Interactive Cancer Communication System (ICCS) in Lung CancerCompletedNCT01012401Not applicable
- Trial of ZD6474 and Faslodex in Non-Small Cell Lung CancerWithdrawnNCT01004419Phase 1
- Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung CancerCompletedNCT00954278Phase 1
- Thoracic OncoGeriatric Assessment (TOGA) TrialsCompletedNCT00591981
- Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung CancerCompletedNCT00582634Phase 2
- NM404 as an Imaging Agent in Patients With NSCLCCompletedNCT00582283Phase 1
- Erlotinib and Sunitinib in NSCLCCompletedNCT00581789Phase 1
- Web-based Intervention for Lung Cancer Patients and Their Informal CaregiversCompletedNCT00365963Phase 3
- Hypofractionated Radiotherapy for Lung CancerCompletedNCT00214123Phase 1
- Surveillance For New Lung PrimariesTerminatedNCT00205413
- Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung CancerCompletedNCT00064012Phase 2
- Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerCompletedNCT00036790Phase 1
- Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung CancerStatus unknownNCT00004265Phase 2
- Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung CancerStatus unknownNCT00004264Phase 1/2